First "Antisense" Drug Will Treat CMV Retinitis
The DOI matches its Crossref record.
Abstract
A NEW CLASS of therapeutic agents known as "antisense" drugs is likely to become available to physicians within the next few months. These drugs operate at the molecular level, interrupting the process by which disease-causing proteins are produced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“one oligonucleotide, Fomivirsen, has been approved for the treatment of cytomegalovirus retinitis (44).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [44]
Citations
Cites
Still being checked.
Cited by
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 747
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
Braasch, D. A., & Corey, D. R. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00058-2 · Cited by 605
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Design of antisense oligonucleotides stabilized by locked nucleic acids
Kurreck, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1911 · Cited by 577
Metadata
- Authors
- Marwick, C.
- Corresponding author
- Marwick, Charles
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-09-09
- Volume
- 280
- Issue
- 10
- Pages
- 871
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2012222863
- Cited by
- 167
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 1 · 2012: 5
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- antisense therapeutics, cytomegalovirus retinitis, gene therapy, antiviral therapy, protein synthesis inhibition
- MeSH terms
- Antiviral Agents, Humans, Thionucleotides, AIDS-Related Opportunistic Infections, Cytomegalovirus Retinitis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First "Antisense" Drug Will Treat CMV Retinitis. https://app.cochat.ai/papers/10.1001/jama.280.10.871-jmn0909-6-1
- The paper
- Marwick, C. (1998). First "Antisense" Drug Will Treat CMV Retinitis. JAMA. https://doi.org/10.1001/jama.280.10.871-jmn0909-6-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.